{
  "retracted": false,
  "timestamp": 1353542400000,
  "updates": [
    {
      "timestamp": 1585376388139,
      "identifier": {
        "doi": "10.1007/bf03259762"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.2165/00042310-199302090-00002"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to Gliclazide: good clinical profile but relatively high acquisition costs"
}
